Cizzle Biotechnology Holdings PLC - Asset Resilience Ratio

Latest as of December 2023: 83.46%

Cizzle Biotechnology Holdings PLC (CIZ) has an Asset Resilience Ratio of 83.46% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Cizzle Biotechnology Holdings PLC total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

GBX1.41 Million

≈ $171.92 USD Cash + Short-term Investments

Total Assets

GBX1.69 Million

≈ $205.99 USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2023)

This chart shows how Cizzle Biotechnology Holdings PLC's Asset Resilience Ratio has changed over time. See Cizzle Biotechnology Holdings PLC (CIZ) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Cizzle Biotechnology Holdings PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CIZ company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX1.41 Million	83.46%
Total Liquid Assets	GBX1.41 Million	83.46%

Asset Resilience Insights

Very High Liquidity: Cizzle Biotechnology Holdings PLC maintains exceptional liquid asset reserves at 83.46% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Cizzle Biotechnology Holdings PLC Industry Peers by Asset Resilience Ratio

Compare Cizzle Biotechnology Holdings PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.10%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	4.52%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	35.56%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Cizzle Biotechnology Holdings PLC (2023–2023)

The table below shows the annual Asset Resilience Ratio data for Cizzle Biotechnology Holdings PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	83.46%	GBX1.41 Million ≈ $171.92	GBX1.69 Million ≈ $205.99	--

pp = percentage points

About Cizzle Biotechnology Holdings PLC

LSE:CIZ UK Biotechnology

Market Cap

$127.81K

GBX1.05 Billion GBX

Market Cap Rank

#30925 Global

#1075 in UK

Share Price

GBX2.65

Change (1 day)

+0.00%

52-Week Range

GBX1.29 - GBX2.80

All Time High

GBX1144.91